# Exploring the link between glycated serum protein and esophageal metrics in diabetic GERD patients

**Authors:** JingXia Wang, QiaoQiao Kong, Jing Chen, HePing Xia, MaoLin Han, ChuangZhou Xie, Ning You

PMC · DOI: 10.1515/med-2025-1373 · 2026-03-09

## TL;DR

This study explores how glycated serum protein relates to esophageal function in diabetic patients with GERD, finding significant correlations and predictive potential.

## Contribution

The novel contribution is identifying glycated serum protein as an independent risk factor for GERD in diabetic patients.

## Key findings

- Elevated glycated serum protein is an independent risk factor for GERD in diabetic patients.
- PSPW and BI are independent protective factors against GERD.
- A linear relationship exists between GSP, PSPW, BI, and GERD prevalence risk.

## Abstract

This study assessed the relationship between glycated serum protein (GSP) and post-reflux swallow-induced peristaltic wave (PSPW) index and esophageal baseline impedance (BI) in patients with diabetes mellitus (DM) with gastroesophageal reflux disease (GERD).

General clinical data of patients in the DM and DM/GERD groups were compared. Multifactorial Logistic regression analyses were performed to screen for independent factors on GERD in DM patients, and odds ratio (OR) was calculated. The risk of GERD was assessed using a spline regression model constructed on the basis of GSP, PSPW and BI. Predictive efficacy was analyzed using Receiver operating curve (ROC) curve analysis.

Statistically significant differences were found in TG, hs-CRP, GSP, PSPW, and BI between patients in the DM and DM/GERD groups. PSPW and BI (OR=0.99, p<0.01) were independent protective factors, and elevated GSP was an independent risk factor for the development of GERD. A linear relationship was validated between GSP and PSPW and BI and the prevalence risk of developing GERD in patients with DM, all with good predictive efficacy.

GSP, PSPW, and BI show significant correlations with the onset and progression of GERD in patients and all demonstrate good predictive efficacy. However, due to the small size of the patient cohort, the generalizability of these findings requires further validation.

## Linked entities

- **Diseases:** diabetes mellitus (MONDO:0005015), gastroesophageal reflux disease (MONDO:0007186)

## Full-text entities

- **Genes:** ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, SERPINC1 (serpin family C member 1) [NCBI Gene 462] {aka AT3, AT3D, ATIII, ATIII-R2, ATIII-T1, ATIII-T2}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, F3 (coagulation factor III, tissue factor) [NCBI Gene 2152] {aka CD142, TF, TFA}, GSM1 (geniospasm 1) [NCBI Gene 2933] {aka GSP}, LOC102724197 (inactive glutathione hydrolase 2) [NCBI Gene 102724197] {aka GGT2}, GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}
- **Diseases:** superficial gastritis (MESH:D005756), esophageal hiatal hernia (MESH:D006551), autonomic neuropathy (MESH:D009422), infectious diseases (MESH:D003141), esophageal dyskinesia (MESH:D004409), cardiac disease or renal dysfunctions (MESH:D007674), mucosal injury (MESH:D052016), hoarseness (MESH:D006685), heartburn (MESH:D006356), gastrointestinal tumor (MESH:D005770), coagulation dysfunction (MESH:D001778), esophageal dysfunction (MESH:D004935), diabetic neuropathy (MESH:D003929), immune system diseases (MESH:D007154), peptic ulcer (MESH:D010437), ERD (MESH:D014077), cough (MESH:D003371), insulin resistance (MESH:D007333), vagus nerve damage (MESH:D061223), PSPW (MESH:D003680), hematological disorders (MESH:D006402), neurological damage (MESH:D020196), hyperglycemic (MESH:D006944), Hypertension (MESH:D006973), death (MESH:D003643), nerve damage (MESH:D000080902), reflux retention (MESH:D016055), metabolic disorder (MESH:D008659), halitosis (MESH:D006209), acid regurgitation (MESH:D008944), burning (MESH:D002056), esophageal mucosal injury (MESH:D004941), rash (MESH:D005076), obesity (MESH:D009765), chest pain (MESH:D002637), DM (MESH:D003920), tumors (MESH:D009369), GERD (MESH:D005764), inflammation (MESH:D007249), Gastrointestinal symptoms (MESH:D012817), Hyperglycemia (MESH:D006943)
- **Chemicals:** alcohol (MESH:D000438), creatinine (MESH:D003404), glucose (MESH:D005947), Lipid (MESH:D008055), Urea (MESH:D014508), Cre (-), cholesterol (MESH:D002784), blood glucose (MESH:D001786), AGEs (MESH:D017127), Nitrogen (MESH:D009584), TG (MESH:D014280), acid (MESH:D000143)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12965830/full.md

---
Source: https://tomesphere.com/paper/PMC12965830